Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  NASDAQ OMX STOCKHOLM  >  Kinnevik    KINV B   SE0008373906

KINNEVIK

(KINV B)
  Report  
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsOfficial PublicationsSector newsAnalyst Recommendations

Kinnevik participates with USD 50 million in Babylon's funding round

share with twitter share with LinkedIn share with facebook
share via e-mail
0
08/01/2019 | 07:03pm EDT

Kinnevik AB (publ) (“Kinnevik”), today announced that it will participate with a USD 50m investment in a fundraise of up to USD 500m by Babylon Holdings Limited (“Babylon”), the digital healthcare service company combining mobile tech and artificial intelligence with medical expertise. After the first close of the raise of USD 400m, Kinnevik is expected to own 16.2 per cent of Babylon on a fully diluted basis. Assuming a final close of the raise of USD 500m, Kinnevik is expected to own 15.0 per cent in Babylon on a fully diluted basis. The USD 500m raise corresponds to a post-money valuation of USD 2.0bn.

Kinnevik first invested in Babylon in January 2016, and since then the company has created a unique end-to-end platform that has the capability to provide AI-driven health services and virtual medical consultations, complemented by traditional face-to-face consultations. The funding round will enable Babylon to further deliver on its growth and innovation strategy and the proceeds will support the advancement of its suite of products and pioneering AI technology while increasing its global footprint, particularly in the United States.

Kinnevik’s participation in the funding round includes the conversion of USD 19m in previously provided financing prior to 30 June 2019.

Kinnevik’s CEO, Georgi Ganev commented: “We are delighted to welcome new strategic and financial partners into Babylon and are pleased that they recognize the company’s growth potential which we have been enthusiastic about since our first investment in early 2016. We are looking forward to entering this next chapter in Babylon’s journey, and to continuing to support them in their mission to put accessible and affordable healthcare into the hands of everyone on earth. “

This information is information that Kinnevik AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out below, at 01.00 CET on 2 August 2019.

For further information, visit www.kinnevik.com or contact:

Torun Litzén, Director Investor Relations
Phone +46 (0)70 762 00 50
Email press@kinnevik.com

Attachment

Primary Logo


© GlobeNewswire 2019
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on KINNEVIK
06:59aKinnevik proposes to distribute its entire Millicom shareholding to its share..
GL
09/16KINNEVIK : completes accelerated bookbuild of shares in Zalando
PU
09/16KINNEVIK : Results of the accelerated bookbuild of shares in Zalando
GL
09/16KINNEVIK : launches accelerated bookbuild of shares in Zalando
PU
09/16KINNEVIK : Launch of accelerated bookbuild of shares in Zalando
GL
09/04NEWS HIGHLIGHTS : Top Company News of the Day
DJ
08/01Kinnevik participates with USD 50 million in Babylon's funding round
GL
07/31Kinnevik confirms preparations for a fundraise in Babylon Holdings Limited
GL
07/25Pricing of Livongo's IPO
GL
07/19GLOBAL MARKETS LIVE : T-Mobile, Sprint, Boeing, AB InBev…
More news
Financials (SEK)
Sales 2019 1 354 M
EBIT 2019 3 759 M
Net income 2019 2 638 M
Debt 2019 5 072 M
Yield 2019 3,15%
P/E ratio 2019 27,9x
P/E ratio 2020 32,4x
EV / Sales2019 58,2x
EV / Sales2020 80,0x
Capitalization 73 787 M
Chart KINNEVIK
Duration : Period :
Kinnevik Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends KINNEVIK
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 8
Average target price 275,86  SEK
Last Close Price 266,10  SEK
Spread / Highest target 21,0%
Spread / Average Target 3,67%
Spread / Lowest Target -24,8%
EPS Revisions
Managers
NameTitle
Georgi Martin Ganev Chief Executive Officer
Amelia Chilcott Fawcett Chairman
Per Martin Joakim Andersson Chief Financial Officer
Magnus Jakobson Director-Finance
Wilhelm Klingspor Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
KINNEVIK28.40%7 769
INVESTOR AB26.01%36 803
CK HUTCHISON HOLDINGS LTD-5.71%35 267
HAL TRUST3.00%12 583
KOC HOLDING AS--.--%8 309
REMGRO LIMITED-6.93%7 122